- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03033953
Effects of Native Whey or Milk Supplementation on Adaptations to 12 Weeks of Strength Training in Young and Elderly
Effects of Native Whey and Milk Supplementation on Changes in Muscle Mass and Strength After 12 Weeks of Strength Training in Young and Elderly
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than milk. Of special interest is the higher amounts of the highly anabolic amino acid leucine in native whey.
The higher levels of leucine can be of great interest for elderly individuals as some studies in elderly has shown an anabolic resistance to the effects of protein feeding and strength training. By increasing levels of leucine one might overcome this anabolic resistance in the elderly.
The aim of this double-blinded, randomized, partial cross-over study is to compare the changes in muscle hypertrophy and strength after a 11 (elderly) or 12 (young) week training intervention with daily supplementation of either 2x20g of native whey or milk proteins in young and elderly individuals. In order to explain potential differences between supplements an acute study investigating acute responses in blood amino acid concentrations and intracellular signalling is planned, in a subgroup of participants, before and after the training intervention.
The investigators hypothesize that native whey will induce greater muscle hypertrophy and strength gains than milk.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Oslo, Noruega, 0863
- Norwegian School of Sport Sciences
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Healthy in the sense that they can conduct training and testing
- Able to understand Norwegian language written and oral
- Between 20 and 45, or above 70 years of age
Exclusion Criteria:
- Diseases or injuries contraindicating participation
- Use of dietary supplements (e.g. proteins, vitamins and creatine)
- Lactose intolerance
- Allergy to milk
- Allergy towards local anesthetics (xylocain)
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Cuadruplicar
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador de placebos: Milk supplementation
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g milk protein.
|
|
|
Experimental: Native whey
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g native whey protein.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Lean mass
Periodo de tiempo: Before the training intervention
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
Before the training intervention
|
|
Lean mass
Periodo de tiempo: After 11-12 weeks of strength training
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
After 11-12 weeks of strength training
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Thigh muscle cross sectional area
Periodo de tiempo: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
|
Thigh muscle cross sectional area
Periodo de tiempo: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
|
Pectoralis muscle cross sectional area
Periodo de tiempo: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
|
Pectoralis muscle cross sectional area
Periodo de tiempo: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
|
Arm cross sectional area
Periodo de tiempo: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
|
Arm cross sectional area
Periodo de tiempo: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
|
Thickness of the lateral vasti
Periodo de tiempo: Before the training intervention
|
Measured by ultrasound
|
Before the training intervention
|
|
Thickness of the lateral vasti
Periodo de tiempo: After 11-12 weeks of strength training
|
Measured by ultrasound
|
After 11-12 weeks of strength training
|
|
1 repetition maximum in leg press
Periodo de tiempo: Before the training intervention
|
Before the training intervention
|
|
|
1 repetition maximum in leg press
Periodo de tiempo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
1 repetition maximum in bench press
Periodo de tiempo: Before the training intervention
|
Before the training intervention
|
|
|
1 repetition maximum in bench press
Periodo de tiempo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Periodo de tiempo: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Periodo de tiempo: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Periodo de tiempo: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Periodo de tiempo: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Periodo de tiempo: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Periodo de tiempo: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Plasma amino acid concentration
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Plasma amino acid concentration
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Muscle force generating capacity change from baseline
Periodo de tiempo: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
|
Muscle force generating capacity change from baseline
Periodo de tiempo: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum glucose
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum glucose
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Serum insulin
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum insulin
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Serum urea
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum urea
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Serum creatine kinase
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum creatine kinase
Periodo de tiempo: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Tumor necrosis factor alfa messenger ribonucleic acid (mRNA)
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Tumor necrosis factor alfa mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Tumor necrosis factor alfa mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Tumor necrosis factor alfa mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 6 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 6 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 6 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 6 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 8 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 8 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 8 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 8 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1b mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 1b mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 1b mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1b mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 4 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 4 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 4 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 4 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 10 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 10 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 10 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 10 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Cholesterol 25-Hydroxylase mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Cholesterol 25-Hydroxylase mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Cholesterol 25-Hydroxylase mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Cholesterol 25-Hydroxylase mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 17D mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 17D mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 17D mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 17D mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Uncoupling Protein 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Uncoupling Protein 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Uncoupling Protein 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Uncoupling Protein 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Matrix Metallopeptidase 9 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Matrix Metallopeptidase 9 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Matrix Metallopeptidase 9 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Matrix Metallopeptidase 9 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Toll Like Receptor 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Toll Like Receptor 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Toll Like Receptor 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Toll Like Receptor 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Atrogin-1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Atrogin-1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Atrogin-1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Atrogin-1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box Protein O1A mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Forkhead Box Protein O1A mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Forkhead Box Protein O1A mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box Protein O1A mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box O3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Forkhead Box O3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Forkhead Box O3 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box O3 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 7 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 7 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 7 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 7 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 2 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 2 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 1mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Periodo de tiempo: 30 min after exercise and protein intake, after 11-12 weeks of strength training
|
30 min after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Fasting cholesterol (only in elderly)
Periodo de tiempo: Before training intervention
|
Before training intervention
|
|
|
Fasting cholesterol (only in elderly)
Periodo de tiempo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Fasting triglycerides (only in elderly)
Periodo de tiempo: Before training intervention
|
Before training intervention
|
|
|
Fasting triglycerides (only in elderly)
Periodo de tiempo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Fasting LDL (only in elderly)
Periodo de tiempo: Before training intervention
|
Before training intervention
|
|
|
Fasting LDL (only in elderly)
Periodo de tiempo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Fasting HDL (only in elderly)
Periodo de tiempo: Before training intervention
|
Before training intervention
|
|
|
Fasting HDL (only in elderly)
Periodo de tiempo: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- Tine 12wk
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Entrenamiento de fuerza
-
Northwestern UniversityReclutamientoApnea obstructiva del sueño (AOS)Estados Unidos
-
Fenerbahce UniversityAcibadem Maslak HospitalAún no reclutandoCáncer pediátrico | Oncología Pediátrica | Catéter venoso central | Colocación de catéter venoso central | Infección del sitio de salida del catéter venoso centralTurquía (Türkiye)
-
Wuerzburg University HospitalReclutamientoPólipo colónico | Adenoma de colonAlemania
-
Rigshospitalet, DenmarkUniversity of CopenhagenTerminadoResultado de aprendizaje | Eficiencia de entrenamientoDinamarca
-
Ankara Etlik City HospitalReclutamientoOsteoartritis de rodilla | Entrenamiento de equilibrio | Rehabilitación Postoperatoria | Recuperación total de artroplastia de rodillaPavo
-
Diala BurjakTerminadoEducación estudiantil | La formación práctica | Educación en línea | Técnicas de sutura | Eficacia del entrenamientoJordán
-
Johns Hopkins Bloomberg School of Public HealthInnovations for Poverty Action; Investors Club/Enterprise UgandaTerminadoEstrés | Bienestar Psicológico | Dificultad económicaUganda
-
University of New HampshireAmerican Heart Association; California State University, San MarcosTerminadoModificación de la dieta | Ejercicio | Presión arterial | Promoción de la salud | Factor de riesgo cardiovascularEstados Unidos
-
Queen's UniversityTerminadoEficacia del Cuaderno de Recuperación como Herramienta Psicoeducativa para Facilitar la RecuperaciónDesordenes mentalesCanadá